Tempest Therapeutics holds special stockholder meeting
TPST•Tempest Therapeutics adjourned its October 14, 2026, special stockholder meeting because a proposed charter amendment lacked enough votes. The meeting will reconvene November 12 to allow further voting on the unchanged proposal.
1. Meeting adjourned
Tempest Therapeutics adjourned its October 14, 2026, special stockholder meeting because a proposed charter amendment lacked sufficient votes for approval. The amendment would replace specified supermajority voting requirements and permit stockholder action by written consent; it remains unapproved.
2. Voting to resume
The meeting will reconvene November 12, 2026, to allow additional voting on the unchanged proposal.
